Cosmos Health Inc., a global healthcare group, has purchased $500,000 worth of Bitcoin, increasing its total cryptocurrency investments to $2.5 million. The move builds on its existing Ethereum holdings and signals plans to consider other cryptocurrencies. The acquisition was made at an average price below $70,000 per Bitcoin, as announced on February 11, 2026.
Cosmos Health Inc. (NASDAQ:COSM), a diversified healthcare company incorporated in 2009 in Nevada, announced on February 11, 2026, from Chicago, the expansion of its digital assets program through a $500,000 purchase of Bitcoin (BTC). This investment brings the company's total cryptocurrency holdings to $2.5 million, combining the new Bitcoin acquisition with prior Ethereum (ETH) investments.
The company's digital assets strategy has previously centered on Ethereum, which will continue as a key component. However, the addition of Bitcoin marks a strategic shift toward broader exposure to established digital assets. Cosmos Health plans to selectively evaluate other cryptocurrencies for inclusion, depending on market conditions and alignment with its financial goals. This approach aims to enhance flexibility, diversification, and opportunities, including potential tokenization of high-value intellectual property.
The Bitcoin purchase was executed at an average price below $70,000 per unit, described by the company as a disciplined and opportunistic deployment of capital during market sell-offs. Greg Siokas, CEO of Cosmos Health, commented: "Our digital assets strategy is designed to be adaptive, disciplined, and opportunistic. The decision to invest in Bitcoin, executed at an average price below $70,000 per Bitcoin, reflects our view that deploying capital during periods of intense market sell-offs can create value over time. While Ethereum remains a key pillar of our digital assets program, we believe that adding Bitcoin, along with the potential inclusion of other select cryptocurrencies, enhances diversification and strengthens our overall capital deployment strategy."
This expansion fits into Cosmos Health's broader capital framework, supported by a Form S-3 shelf registration filed on November 7, 2025, allowing up to $200 million in securities, including a $100 million at-the-market program. Proceeds are intended for cryptocurrency acquisitions as treasury assets, general corporate purposes, and working capital.
Cosmos Health operates a vertically integrated global healthcare group, manufacturing pharmaceuticals and nutraceuticals under European GMP standards through subsidiaries like Cana Laboratories S.A. It distributes products across Europe, Asia, and North America, and has ventured into telehealth via ZipDoctor, Inc.
